Psilocybin Therapy for Chronic Low Back Pain — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Psilocybin Therapy for Chronic Low Back Pain — Stella

Home/Chronic Low-back Pain/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Low-back Pain trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

University of California San Francisco, San Francisco, California

Key details

Phase

Early testing / Safety & dosing

Sponsor

Joshua Woolley, MD, PhD

Enrollment target

~30 participants

Started

December 2023

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

25 Years – 70 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.